Effects of dual endothelin receptor blockade on sympathetic activation and arrhythmogenesis during acute myocardial infarction in rats

European Journal of Pharmacology

Volumn 580, Issue 1-2, 2008, Pages 241-249

  Kolettis, Theofilos M ^a   Baltogiannis, Giannis G ^a   Tsalikakis, Dimitrios G ^a   Tzallas, Alexandros T ^a   Agelaki, Maria G ^a   Fotopoulos, Andreas ^a   Fotiadis, Dimitrios I ^a   Kyriakides, Zenon S ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

Autonomic nervous system; Catecholamines; Endothelin 1; Myocardial infarction; Ventricular tachyarrhythmias

Indexed keywords

ADRENALIN; BOSENTAN; CATECHOLAMINE; NORADRENALIN;

ACTION POTENTIAL; ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION SIZE; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDER; REPERFUSION INJURY; REPOLARIZATION; SYMPATHETIC TONE;

ACTION POTENTIALS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ELECTROCARDIOGRAPHY; EPINEPHRINE; MYOCARDIAL INFARCTION; NOREPINEPHRINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SULFONAMIDES; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA, VENTRICULAR; TELEMETRY; VENTRICULAR FIBRILLATION;

EID: 37649022744     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.002     Document Type: Article

References (50)

1. Alberola Aguilar A.M., Revert F., Moya A., Beltran J., Garcia J., San Martin E., Sancho S., and Such L. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion. Gen. Pharmacol. 35 (2000) 143-147
2. Alexiou K., Dschietzig T., Simsch O., Laule M., Hundertmark J., Baumann G., and Stangl K. Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin: aggravation of this phenomenon in heritable hyperlipidemia. J. Am. Coll. Cardiol. 32 (1998) 1773-1778
3. Baltogiannis G.G., Tsalikakis D.G., Mitsi A.C., Hatzistergos K.E., Elaiopoulos D., Fotiadis D.I., Kyriakides Z.S., and Kolettis T.M. Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc. Res. 67 (2005) 647-654
4. Becker R., Merkely B., Bauer A., Geller L., Fazekas L., Freigang K.D., Voss F., Senges J.C., Kuebler W., and Schoels W. Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping. Cardiovasc. Res. 45 (2000) 310-320
5. Clements-Jewery H., Hearse D.J., and Curtis M.J. Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br. J. Pharmacol. 145 (2005) 551-564
6. Clozel M., Qiu C., Qiu C.S., Hess P., and Clozel J.P. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction. J. Am. Coll. Cardiol. 39 (2002) 142-147
7. Corr P.B., and Gillis R.A. Autonomic neural influences on the dysrhythmias resulting from myocardial infarction. Circ. Res. 43 (1978) 1-9
8. Crockett T.R., Sharif I., Kane K.A., and Wainwright C.L. Sarafotoxin 6c protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J. Cardiovasc. Pharmacol. 36 (2000) S297-S299
9. Curtis M.J., and Walker M.J.A. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischemia. Cardiovasc. Res. 22 (1988) 656-665
10. Douglas S.A., Nichols A.J., Feuerstein G.Z., Elliott J.D., and Ohlstein E.H. SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog. J. Cardiovasc. Pharmacol. 31 Suppl 1 (1998) S99-S102
11. Duru F., Barton M., Luescher T.F., and Candinas R. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?. Cardiovasc. Res. 49 (2001) 272-280
12. Fenoglio Jr. J.J., Karagueuzian H.S., Friedman P.L., Albala A., and Wit A.L. Time course of infarct growth toward the endocardium after coronary occlusion. Am. J. Physiol. 236 (1979) H350-H356
13. Fraccarollo D., Hu K., Galuppo P., Gaudron P., and Ertl G. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation 96 (1997) 3963-3973
14. Fraccarollo D., Galuppo P., Bauersachs J., and Ertl G. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling. Cardiovasc. Res. 54 (2002) 559-567
15. Franz M.R. Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc. Res. 41 (1999) 25-40
16. Gelzer A.R., Attmann T., Radicke D., Nydam D., Candinas R., and Lutter G. Effects of acute systemic endothelin receptor blockade on cardiac electrophysiology in vivo. J. Cardiovasc. Pharmacol. 44 (2004) 564-570
17. Geshi E., Nomizo A., Arata Y., Nakatani M., and Katagiri T. Effect of non-selective endothelin blockade, TAK-044, on the ischemic cellular injury of rat heart. Basic Res. Cardiol. 94 (1999) 94-101
18. Hu K., Gaudron P., Schmidt T.J., Hoffmann K.D., and Ertl G. Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction. J. Cardiovasc. Pharmacol. 32 (1998) 505-508
19. Isaka M., Kudo A., Imamura M., Kawakami H., and Yasuda K. Endothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmias. Basic Res. Cardiol. 102 (2007) 154-162
20. Kelso E.J., Spiers J.P., McDermott B.J., Scholfield C.N., and Silke B. Receptor-mediated effects of endothelin on the L-type Ca+ current in ventricular cardiomyocytes. J. Pharmacol. Exp. Ther. 286 (1998) 662-669
21. Kruger C., Kalenka A., Haunstetter A., Schweizer M., Maier C., Ruhle U., Ehmke H., Kubler W., and Haass M. Baroreflex sensitivity and heart rate variability in conscious rats with myocardial infarction. Am. J. Physiol. 273 (1997) H2240-H2247
22. Lameris T.W., de Zeeuw S., Alberts G., Boomsma F., Duncker D.J., Verdouw P.D., Veld A.J., and van den Meiracker A.H. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation 101 (2000) 2645-2650
23. Li W., Knowlton D., Van Winkle D.M., and Habecker B.A. Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons. Am. J. Physiol, Heart Circ. Physiol. 286 (2004) H2229-H2236
24. Loennechen J.P., Stoylen A., Beisvag V., Wisloff U., and Ellingsen O. Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart. Am. J. Physiol, Heart Circ. Physiol. 280 (2001) H2902-H2910
25. McCabe C., Hicks M.N., Kane K.A., and Wainwright C.L. Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts. Br. J. Pharmacol. 146 (2005) 118-128
26. Merkely B., Geller L., Toth M., Kiss O., Kekesi V., Solti F., Vecsey T., Horkay F., Tenczer J., and Juhasz-Nagy A. Mechanism of endothelin-induced malignant ventricular arrhythmias in dogs. J. Cardiovasc. Pharmacol. 31 Suppl 1 (1998) S437-S439
27. Molenaar P., O'Reilly G., Sharkey A., Kuc R.E., Harding D.P., Plumpton C., Gresham G.A., and Davenport A.P. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ. Res. 72 (1993) 526-538
28. Mulder P., Richard V., Derumeaux G., Hogie M., Henry J.P., Lallemand F., Compagnon P., Macé B., Comoy E., Letac B., and Thuillez C. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96 (1997) 1976-1982
29. Nagayama T., Kuwakubo F., Matsumoto T., Fukushima Y., Yoshida M., Suzuki-Kusaba M., Hisa H., Matsumura Y., Kimura T., and Satoh S. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland. Eur. J. Pharmacol. 406 (2000) 69-74
30. Nguyen Q.T., Cernacek P., Calderoni A., Stewart D.J., Picard P., Sirois P., White M., and Rouleau J.L. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. Circulation 98 (1998) 2323-2330
31. Nguyen Q.T., Cernacek P., Sirois M.G., Calderone A., Lapointe N., Stewart D.J., and Rouleau J.-L. Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat. Importance of timing. Circulation 104 (2001) 2075-2081
32. Oie E., Bjonerheim R., Grogaard H.K., Kongshaug H., Smiseth O.A., and Attramadal H. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats. Am. J. Physiol. 275 (1998) H868-H877
33. Opitz C.F., Mitchell G.F., Pfeffer M.A., and Pfeffer J.M. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92 (1995) 253-261
34. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., and Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44 (1979) 503-512
35. Proven A., Roderick H.L., Conway S.J., Berridge M.J., Horton J.K., Capper S.J., and Bootman M.D. Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes. J. Cell Sci. 119 (2006) 3363-3375
36. Raschack M., Juchelka F., and Rozek-Schaefer G. The endothelin-A antagonist LU 135 252 supresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling. J. Cardiovasc. Pharmacol. 31 Suppl 1 (1998) S145-S148
37. Richard V., Kaeffer N., Hogie M., Tron C., Blanc T., and Thuillez C. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br. J. Pharmacol. 113 (1994) 869-876
38. Rosengren A., Wallentin L., Gitt K., Behar S., Battler A., and Hasdai D. Sex, age, and clinical presentation of acute coronary syndromes. Eur. Heart J. 25 (2004) 663-670
39. Schomig A., Haass M., and Richardt G. Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur. Heart J. 12 (1991) 38-47 (Suppl F)
40. Sharif I., Kane K.A., and Wainwright C.L. Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?. Cardiovasc. Res. 39 (1998) 625-632
41. Stewart D.J., Kubac K.B., Costello K.B., and Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18 (1991) 38-43
42. Szokodi I., Horkay F., Merkely B., Solti F., Geller L., Kiss P., Selmeci L., Kekesi V., Vuolteenaho O., Ruskoaho H., Juhasz-Nagy A., and Toth M. Intraepicardial infusion of endothelin-1 induces ventricular arrhythmias in dogs. Cardiovasc. Res. 38 (1998) 356-364
43. Tsalikakis D.G., Fotiadis D.I., Kolettis T., and Michalis L.K. Automated system for the analysis of heart monophasic action potentials. Comput. Cardiol. 30 (2003) 339-342
44. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., and Harron D.W. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
45. Wang Q.D., Li X.S., Lundberg J.M., and Pernow J. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc. Res. 29 (1995) 805-812
46. Wennmalm A., Karwatowska-Prokopczuk E., and Wennmalm M. Role of the coronary endothelium in the regulation of sympathetic transmitter release in isolated rabbit hearts. Acta Physiol. Scand. 136 (1989) 81-87
47. Yasuda M., Kohno M., Tahara A., Itagane H., Toda I., Akioka K., Teragaki M., Oku H., Takeuchi K., and Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am. Heart J. 119 (1990) 801-806
48. Yorikane R., Koike H., and Miyake S. Electrophysiological effects of endothelin-1 on canine myocardial cells. J. Cardiovasc. Pharmacol. 17 Suppl 7 (1991) S159-S162
49. Ytrehus K., Liu Y., Tsuchida A., Miura T., Liu G.S., Yang X.M., Herbert D., Cohen M.V., and Downey J.M. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am. J. Physiol 267 (1994) H2383-H2390
50. Zheng Z.J., Croft J.B., Giles W.H., and Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 (2002) 2158-2163